How often should copper levels be monitored during GHK-Cu therapy in liver disease
Side effects were consistent with the GLP-1 drug class, including nausea, diarrhea, and vomiting
Historically, weight loss medications relied on central nervous system stimulants like phentermine, which carried significant cardiovascular risks, sleep disruption, and high rates of rebound weight gain once stopped
GLP-1 receptor agonists like semaglutide and liraglutide, and dual GIP/GLP-1 receptor agonists like tirzepatide, slow gastric emptying, reduce appetite, and improve insulin sensitivity
In the scalp, that widening increases blood flow to hair follicles, delivering more oxygen and nutrients to support active growth